‘Coincidence that PM Modi acquired Covaxin’: Owaisi raises questions over Covishield’s efficacy

Image Source : PTI (FILE) AIMIM chief and Hyderabad MP Asaduddin Owaisi
AIMIM chief Asaduddin Owaisi has questioned the efficacy of Covishield, one of many two anti-coronavirus vaccines authorised by the DGCI for emergency use. Owaisi, whereas citing a German authorities report has claimed that, Covishield is efficient for these between 18 and 64 years and it would not work who’re above 64.

“Everybody in the country will have to take coronavirus vaccine be it Covishield or Covaxin. I have one question, the German government said that Covishield, the Oxford-AstraZeneca vaccine which is being manufactured by the Serum Institute of India… the data published on the website of AstraZeneca says that it is good for people between 18 and 64 years. It is not effective on those above 64,” he mentioned.

“It is a coincidence that PM Modi received a Covaxin shot. I want to request the government to clear the confusion,” the Hyderabad MP added and exuded hope that vaccine will attain each nook and nook of the nation.

Covaxin is the second vaccine that has been granted emergency use nod by the DGCI. Covaxin is a totally indigenous vaccine developed by Hyderabad-based Bharat Biotech.

READ MORE: PM Modi will get Bharat Biotech’s Covaxin jab, urges these eligible to get vaccinated

READ MORE: Covishield not suggested to these allergic to any of its components: Serum Institute of India

Latest India News